MENU

Fox Chase Cancer Center News

Dr. Richard I. Fisher, President and CEO of Fox Chase Cancer Center
November 12, 2018

Press Ganey Recognizes Fox Chase Cancer Center with 2018 Guardian of Excellence Award

PHILADELPHIA (November 12, 2018) – The Press Ganey Guardian of Excellence Award recognizes outstanding clinical performance by our physicians and support staff in our outpatient clinics.

Stephanie E. Weiss, MD, FASTRO
November 8, 2018

Stereotactic Radiosurgery and Surgical Resection Offer Similar Local Control of Brain Metastases

Stereotactic radiosurgery (SRS) offered results comparable to surgery in controlling local brain metastases, Fox Chase Cancer Center researchers have found. Early local control of treated lesions was better with SRS compared to those treated surgically, although the relative benefit decreased with time.

Professor Warren Kruger
November 6, 2018

Scientists Develop Mouse Model to Enable Study of Rare Genetic Disorder Classical Homocystinuria

PHILADELPHIA (November 6, 2018) — Researchers at Fox Chase Cancer Center have created a mouse model that will make it possible to advance understanding of cystathionine beta synthase (CBS) deficiency, also known as classical homocystinuria.

Miriam N. Lango, MD, FACS
November 5, 2018

People in Rural Areas Have Much Higher Risk of Larynx Cancer

PHILADELPHIA (November 5, 2018) — According to a new study, individuals living in rural areas are at greater risk of developing laryngeal cancer compared to those living in urban areas, though overall survival did not differ significantly between the two groups. Socioeconomic variables, including insurance status, had a greater impact on outcomes than geography or race.

November 2, 2018

Stephen M. Sykes Receives Department of Defense Grant for Pediatric Leukemia Research

PHILADELPHIA (November 1, 2018) — Stephen M. Sykes PhD, assistant professor in the Blood Cell Development and Function Program at Fox Chase Cancer Center, will conduct studies to assess the therapeutic utility of targeting downstream transcriptional targets and upstream activators within the unfolded protein response (UPR).

November 1, 2018

Johnathan Whetstine Joins the Cancer Epigenetics Program at Fox Chase Cancer

PHILADELPHIA (November 1, 2018) – The new Cancer Epigenetics Program Johnathan Whetstine, PhD, will lead has basic, translational, and clinical research components, all dedicated to better understanding epigenetic regulation in cancer.

November 1, 2018

Fox Chase Cancer Center Welcomes Diagnostic Radiologist Meghan Boros

PHILADELPHIA (November 1, 2018) – Fox Chase Cancer Center is pleased to announce the hiring of Meghan Boros, MD, who will be joining the department of Diagnostic Imaging, specializing in breast imaging.

John Karanicolas, PhD
October 30, 2018

John Karanicolas Receives Grant from the National Science Foundation

The goal of this grant is to train, test, and use a deep learning model for predicting kinase inhibitor selectivity. The project is entitled “D3SC: EAGER: Deep Learning to Design Selective Kinase Inhibitors.”

Pages

Connect with Fox Chase